Cargando…
The combinatorial activation of the PI3K and Ras/MAPK pathways is sufficient for aggressive tumor formation, while individual pathway activation supports cell persistence
A high proportion of human tumors maintain activation of both the PI3K and Ras/MAPK pathways. In basal-like breast cancer (BBC), PTEN expression is decreased/lost in over 50% of cases, leading to aberrant activation of the PI3K pathway. Additionally, BBC cell lines and tumor models have been shown t...
Autores principales: | Thompson, Keyata N., Whipple, Rebecca A., Yoon, Jennifer R., Lipsky, Michael, Charpentier, Monica S., Boggs, Amanda E., Chakrabarti, Kristi R., Bhandary, Lekhana, Hessler, Lindsay K., Martin, Stuart S., Vitolo, Michele I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4742101/ https://www.ncbi.nlm.nih.gov/pubmed/26497685 |
Ejemplares similares
-
Pharmacologic regulation of AMPK in breast cancer affects cytoskeletal properties involved with microtentacle formation and re-attachment
por: Chakrabarti, Kristi R., et al.
Publicado: (2015) -
ROCK inhibition promotes microtentacles that enhance reattachment of breast cancer cells
por: Bhandary, Lekhana, et al.
Publicado: (2015) -
Parthenolide and costunolide reduce microtentacles and tumor cell attachment by selectively targeting detyrosinated tubulin independent from NF-κB inhibition
por: Whipple, Rebecca A, et al.
Publicado: (2013) -
Overcoming resistance to single-agent therapy for oncogenic BRAF gene fusions via combinatorial targeting of MAPK and PI3K/mTOR signaling pathways
por: Jain, Payal, et al.
Publicado: (2017) -
Catabolic pathways regulated by mTORC1 are pivotal for survival and growth of cancer cells expressing mutant Ras
por: Sung, Suhyun, et al.
Publicado: (2015)